← Back to Search

Antiparasitic

Nitazoxanide for COVID-19

Phase 3

Waitlist Available

Research Sponsored by Romark Laboratories L.C.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 6 weeks

Awards & highlights

Study Summary

This trial will test a drug to help protect healthcare workers and others at risk of getting COVID-19 from infection.

Who is the study for?

This trial is for healthcare workers and others at high risk of COVID-19, who have been exposed to the virus or frequently engage in social activities without distancing. Participants must be adults with internet access, willing to follow study procedures.Check my eligibility

What is being tested?

The trial tests Nitazoxanide (NTZ) as a preventive treatment against COVID-19 and other viral respiratory illnesses, comparing it with a placebo and Vitamin Super B-Complex among those at increased infection risk.See study design

What are the potential side effects?

While not specified here, common side effects of NTZ may include stomach pain, nausea, vomiting, headache. Side effects are generally mild but can vary from person to person.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The proportion of subjects with symptomatic laboratory-confirmed COVID-19 identified after start of treatment and before the end of the 6-week treatment period.

The proportion of subjects with symptomatic laboratory-confirmed VRI identified after the start of treatment and before the end of the 6-week treatment period.

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: NitazoxanideActive Control2 Interventions

Two NTZ 300 mg tablets orally twice daily for 6 weeks.

Group II: PlaceboPlacebo Group2 Interventions

Two placebo tablets orally twice daily for 6 weeks.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Romark Laboratories L.C.Lead Sponsor

28 Previous Clinical Trials

11,400 Total Patients Enrolled

4 Trials studying COVID-19

3,725 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many research centers are actively conducting this experiment?

"Patients are being enrolled at LinQ Research LLC in Pearland, Texas, SMS Clinical Research LLC in Mesquite, Illinois and Rio Grande Valley Clinical Research Institute in Pharr, Louisiana as well as 26 other clinical trial sites."

Answered by AI

Is the age range for this clinical trial inclusive of individuals over fifty years old?

"To qualify for this medical study, applicants must be aged between 18 and 120. Clinicialtrials.gov has 91 trials listed specifically for participants under the age of 18 and 583 that are dedicated to individuals above 65 years old."

Answered by AI

Are opportunities still available to partake in this experiment?

"Clinicaltrials.gov attests that this clinical trial, initially posted on May 13th 2020 and last edited on February 5th 2021, is not currently recruiting for participants. However, 665 other trials are actively seeking patients to join their research at present."

Answered by AI

How does Nitazoxanide affect human health when administered?

"Nitazoxanide has been given a rating of 3 due to the numerous rounds of data which confirm its safety and efficacy, as this is a Phase 3 trial."

Answered by AI

Who meets the criteria for enrollment in this medical trial?

"This trial is recruiting a total of 1407 participants between 18 and 120 years old with active COVID-19. To meet the eligibility criteria, individuals must be at least legal consenting age, provide healthcare to patients or regularly come into close contact with them (less than 6 feet), participate in social activities without accepted social distancing practices three times per week for 7 days prior to enrollment, have access to an internet enabled device and daily online connection, as well as occupational exposure to someone infected by SAR-CoV2 within 1 week before recruitment. All interested parties must also agree and adhere to the requirements outlined in the protocol including providing written"

Answered by AI